Similar articles for PMID: 27485063

Year	Number of Results
1985	1
1987	2
1988	1
1989	3
1990	1
1992	1
1993	1
1994	3
1995	5
1996	2
1997	1
1998	2
1999	2
2000	4
2001	2
2002	3
2004	8
2005	1
2006	3
2007	4
2008	6
2009	10
2010	7
2011	8
2012	16
2013	25
2014	41
2015	38
2016	45
2017	41
2018	46
2019	50
2020	31
2021	27
2022	14
2023	3
2024	0

1

Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.

Ronot M, Cauchy F, Gregoli B, Breguet R, Allaham W, Paradis V, Soubrane O, Vilgrain V. Ronot M, et al. HPB (Oxford). 2016 Aug;18(8):684-90. doi: 10.1016/j.hpb.2016.05.012. Epub 2016 Jun 18. HPB (Oxford). 2016. PMID: 27485063 Free PMC article.

2

Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience.

Marti J, Giacca M, Alshebeeb K, Bahl S, Hua C, Horn JC, BouAyache J, Patel R, Facciuto M, Schwartz M, Florman S, Kim E, Gunasekaran G. Marti J, et al. J Vasc Interv Radiol. 2018 Jul;29(7):920-926. doi: 10.1016/j.jvir.2018.01.780. Epub 2018 May 5. J Vasc Interv Radiol. 2018. PMID: 29735260

3

Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.

Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ. Ye JZ, et al. World J Gastroenterol. 2014 Dec 7;20(45):17141-7. doi: 10.3748/wjg.v20.i45.17141. World J Gastroenterol. 2014. PMID: 25493028 Free PMC article.

4

Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies.

Peng PD, Hyder O, Bloomston M, Marques H, Corona-Villalobos C, Dixon E, Pulitano C, Hirose K, Schulick RD, Barroso E, Aldrighetti L, Choti M, Shen F, Kamel I, Geschwind JF, Pawlik TM. Peng PD, et al. HPB (Oxford). 2012 Aug;14(8):523-31. doi: 10.1111/j.1477-2574.2012.00492.x. Epub 2012 May 31. HPB (Oxford). 2012. PMID: 22762400 Free PMC article.

5

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.

Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Song MJ, et al. Korean J Intern Med. 2016 Mar;31(2):242-52. doi: 10.3904/kjim.2015.112. Epub 2016 Feb 15. Korean J Intern Med. 2016. PMID: 26874512 Free PMC article.

6

Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.

Li HL, Ji WB, Zhao R, Duan WD, Chen YW, Wang XQ, Yu Q, Luo Y, Dong JH. Li HL, et al. World J Gastroenterol. 2015 Mar 28;21(12):3599-606. doi: 10.3748/wjg.v21.i12.3599. World J Gastroenterol. 2015. PMID: 25834326 Free PMC article.

7

Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.

Koh PS, Chan AC, Cheung TT, Chok KS, Dai WC, Poon RT, Lo CM. Koh PS, et al. HPB (Oxford). 2016 Jan;18(1):72-8. doi: 10.1016/j.hpb.2015.07.005. HPB (Oxford). 2016. PMID: 26776854 Free PMC article.

8

Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.

Zhang DZ, Wei XD, Wang XP. Zhang DZ, et al. World J Gastroenterol. 2015 Apr 21;21(15):4635-43. doi: 10.3748/wjg.v21.i15.4635. World J Gastroenterol. 2015. PMID: 25914473 Free PMC article.

9

Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.

Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Ni JY, et al. World J Gastroenterol. 2014 Dec 14;20(46):17483-90. doi: 10.3748/wjg.v20.i46.17483. World J Gastroenterol. 2014. PMID: 25516662 Free PMC article.

10

Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.

Park GC, Lee SG, Yoon YI, Sung KB, Ko GY, Gwon DI, Jung DH, Jung YK. Park GC, et al. Hepatobiliary Pancreat Dis Int. 2020 Jun;19(3):244-251. doi: 10.1016/j.hbpd.2020.04.008. Epub 2020 May 4. Hepatobiliary Pancreat Dis Int. 2020. PMID: 32414576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

406 results

Results by year